retatrutide regulatory approval Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Weight loss drug retatrutide use

Participants were started on lower doses typically 1 mg or 2 mg subcutaneously once weekly and gradually titrated upward over multiple weeks to maintenance doses of 4 mg, 8 mg, or 12 mg administered subcutaneously once weekly

Who Should Consider Prescription GLP-1 Options Over OTC Alternatives Individuals with BMI over 27, metabolic syndrome, prediabetes, or type 2 diabetes have the strongest clinical evidence supporting prescription GLP-1 therapy

10.1152/ajpgi.1981.241.6.G487 Am

These treatments help regulate appetite, reduce cravings, improve insulin sensitivity, and support healthier energy balance for long-term results

And its going to determine who keeps the resultsand who ends up right back where they started

Rather, its an eating approach designed to work alongside GLP-1 medications such as Ozempic, Wegovy, and Mounjaro